China SXT Pharmaceuticals (SXTC) Inventory Average (2018 - 2025)
China SXT Pharmaceuticals (SXTC) recorded quarterly Inventory Average of -$237205.0 in Q3 2025, down 146.4% quarter-over-quarter from $511184.0 in Q1 2025, and down 131.29% on a YoY basis from $758086.5 in Q3 2024.
China SXT Pharmaceuticals (SXTC) Inventory Average (2018 - 2025) Analysis & Trends
China SXT Pharmaceuticals' Inventory Average history runs 8 years deep, the most recent figure standing at -$237205.0 for Q3 2025.
- In Q3 2025, Inventory Average fell 131.29% year-over-year to -$237205.0; the TTM figure through Sep 2025 stood at -$237205.0 (down 131.29% YoY), while the FY2025 annual figure was $547952.5, up 30.29% from the prior year.
- Inventory Average was -$237205.0 for Q3 2025 at China SXT Pharmaceuticals, down from $511184.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $758086.5 in Q3 2024 to a low of -$237205.0 in Q3 2025.
- Historically, Inventory Average has averaged $237038.4 across 5 years, with a median of $170376.0 in 2021.
- The sharpest annual moves came in 2024 and 2025: Inventory Average surged 1028.05% in 2024, then tumbled 131.29% in 2025.
- A 5-year view of Inventory Average shows it stood at $427171.5 in 2021, then tumbled by 87.31% to $54220.5 in 2022, then advanced by 23.94% to $67203.5 in 2023, then soared by 1028.05% to $758086.5 in 2024, then sank by 131.29% to -$237205.0 in 2025.
- The last three Inventory Average figures came in at -$237205.0 (Q3 2025), $511184.0 (Q1 2025), and $758086.5 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.51 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 180.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 131.60 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 66.75 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.73 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 266.66 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 63.01 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 79.60 Mn |
| 10 | China SXT Pharmaceuticals | 177.52 Mn | 156.32 Mn | - | -237,205.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -237,205.00 |
| Mar 31, 2025 | 511,184.00 |
| Sep 30, 2024 | 758,086.50 |
| Mar 31, 2024 | 441,479.00 |
| Sep 30, 2023 | 67,203.50 |
| Mar 31, 2023 | 52,216.00 |
| Sep 30, 2022 | 54,220.50 |
| Mar 31, 2022 | 22,480.00 |
| Sep 30, 2021 | 427,171.50 |
| Mar 31, 2021 | 273,548.50 |
| Sep 30, 2020 | -79,232.00 |
| Mar 31, 2020 | 88,293.00 |
| Sep 30, 2019 | 515,184.50 |
| Mar 31, 2019 | 444,233.00 |
| Sep 30, 2018 | 53,876.00 |